Home / Congress Presentations / C3G and Primary IC-MPGN / Cutting Edge of Transplantation (CEoT) 2026
Landing
Cutting Edge of Transplantation (CEoT) 2026
Pegcetacoplan for Posttransplant Patients with Complement 3 Glomerulopathy or Primary (Idiopathic) Immune-Complex Membranoproliferative Glomerulonephritis
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.